Archive

Review article (Published On: 30-Dec-2019)

Review on the epidemiology and public health importance of Marburg Hemorrhagic Fever in Africa

Samson Terefe Kassa

J. Agri. Res. Adv., 01 (04):27-47

Samson Terefe Kassa: Addis Ababa University, Ethiopia

Download PDF Here

Article History: Received on: 04-Nov-19, Accepted on: 17-Dec-19, Published on: 30-Dec-19

Corresponding Author: Samson Terefe Kassa

Email: terefe.samson@yahoo.com

Citation: Kassa ST (2019). Review on the epidemiology and public health importance of Marburg Hemorrhagic Fever in Africa. J. Agri. Res. Adv., 01 (04):27-47


Abstract

Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe, often fatal illness in humans. Rousettus aegyptiacus, fruit bats of the Pteropodidae family, are considered to be natural hosts of Marburg virus. The Marburg virus is transmitted to people from fruit bats and spreads among humans through human-to-human transmission. The Marburg virus causes severe viral haemorrhagic fever in humans. The average MVD case fatality rate is around 50%. Case fatality rates have varied from 24% to 88% in past outbreaks depending on virus strain and case management. Community engagement is key to successfully controlling outbreaks. Good outbreak control relies on applying a package of interventions, namely case management, infection prevention and control practices, surveillance and contact tracing, a good laboratory service, safe burials and social mobilization. Early supportive care with rehydration, symptomatic treatment improves survival. There is as yet no licensed treatment proven to neutralize the virus but a range of blood, immunological and drug therapies are under development. Marburg virus belongs to the genus Marburg virus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates. Similar to the more widely known Ebola hemorrhagic fever, MHF is characterized by systemic viral replication, immunosuppression and abnormal inflammatory responses. These pathological features of the disease contribute to a number of systemic dysfunctions including hemorrhages, edema, coagulation abnormalities and, ultimately, multiorgan failure and shock, often resulting in death. A detailed understanding of the pathological processes that lead to this devastating disease remains elusive, a fact that contributes to the lack of licensed vaccines or effective therapeutics. This article will review the clinical aspects of MHF and discuss the pathogenesis and possible options for diagnosis, treatment and prevention.


Statistics

Article View: 1199
PDF Downloaded: 50